Arrhythmogenic right ventricular dysplasia:clinical study.
Arrhythmogenic right ventricular dysplasia (ARVD) is a complex arrhythmogenic cardiomyopathy, characterized by a partial or total replacement of the right ventricular myocytes by fatty and fibrous tissue. In this study, we present a case of ARVD in 17 year old girl, who was admitted to the hospital after syncope with ventricular arrhythmia. The echocardiography did not demonstrate structural cardiac abnormalities but the magnetic resonance recently showed thinning of the right ventricular wall. The girl was treated with the lidocaine, amiodarone and next, after radiofrequency catheter ablation she was receiving metoprolol. The girl has remained asymptomatic for four years of follow-up.
Markiewicz-Łoskot
Grazyna
G
Department of Pediatric Cardiology, Medical University of Silesia, Katowice, Poland. ejaniszewska@slam.katowice.pl
Moric-Janiszewska
Ewa
E
Loskot
Maria
M
Szydłowski
Lesław
L
Hollek
Andrzej
A
Weglarz
Ludmiła
L
D000293:Adolescent; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis* / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008790:Metoprolol / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; D008790:Metoprolol; D000638:Amiodarone